Table of Contents

The Role of Intellectual Property Rights in Biotechnology Innovation

The Role of Intellectual Property Rights in Biotechnology Innovation

Edited by David Castle

Intellectual property rights (IPRs), particularly patents, occupy a prominent position in innovation systems, but to what extent they support or hinder innovation is widely disputed. Through the lens of biotechnology, this book delves deeply into the main issues at the crossroads of innovation and IPRs to evaluate claims of the positive and negative impacts of IPRs on innovation.

Chapter 2: Intellectual Property Rights and Innovation Systems: Issues for Governance in a Global Context

Bjørn Asheim, Finn Valentin and Christian Zeller

Subjects: environment, biotechnology, innovation and technology, biotechnology, law - academic, biotechnology and pharmaceutical law, intellectual property law


Bjørn Asheim, Finn Valentin and Christian Zeller INTRODUCTION: WHAT IS AN INNOVATION SYSTEM? This chapter deals with IPRs in innovation systems. Even if both innovation systems and IPRs as such have been studied extensively, the specific problematic of this chapter has hardly been analysed before. This is even more surprising as the form and extent of IPR regulations potentially have big impacts on the functioning of an innovation system. According to Granstrand (2005), ‘IPRs, particularly patents, play several important roles in innovation systems – to encourage innovation and investment in innovation, and to encourage dissemination (diffusion) of information about the principles and sources of innovation throughout the economy’ (Granstrand 2005, p. 280). Thus, the extent, intensity and type of interactions between firms and universities, which represent the constituting relations of an innovation system, will obviously be affected by the way the IPRs are constructed. This is especially the case in science driven activities, such as biotech, which is the focus of this book, being the object of the majority of implemented IPR regulations. This chapter will investigate this problematic through a comparative approach, looking at how IPRs are implemented and their consequences for industry–university collaboration in the US and Europe, with a special focus on Germany, Switzerland and Denmark. While the analyses of the US and Germany and Switzerland give a general account of changes in the IPR regimes, the section on Denmark specifically looks at the consequences for industry– university coloration in biotech by the introduction of Bayh-Dole...

You are not authenticated to view the full text of this chapter or article.

Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.

Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.

Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.

Further information